Aurobindo Pharma receives USFDA Approval for Atomoxetine Capsules
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Atomoxetine capsules, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg. Atomoxetine capsules are the AB rated generic equivalent of Eli Lilly and Company’s Strattera […]
Aurobindo Pharma receives USFDA Approval for Atomoxetine Capsules Read More »